WHO ICTRP trial
A Phase I First Time in Human Open Label Study of GSK3745417 Administered With…
CTIS2024-513574-21-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-513574-21-00 |
|---|---|
| Public title | A Phase I First Time in Human Open Label Study of GSK3745417 Administered With and Without Anticancer Agents in Participants With Advanced Solid Tumors |
| Scientific title | - 208850 |
| Primary sponsor | Glaxosmithkline Research & Development Limited |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Spain;France |
| Conditions | Neoplasms;Therapeutic area: Diseases [C] - Neoplasms [C04] |
| Registration date | May 30, 2024 |
| Target size | 40 |
| Secondary IDs | NCT03843359;2018-001924-20 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: